The Scientist

» VSEL and disease/medicine

Most Recent

image: How Exercise Might Fight Cancer

How Exercise Might Fight Cancer

By | September 8, 2017

Epinephrine’s activation of the signaling pathway Hippo is responsible for the in vitro tumor-fighting effects of serum from women who worked out.

0 Comments

image: Booger Bacteria’s Sweet Immune Suppression

Booger Bacteria’s Sweet Immune Suppression

By | September 6, 2017

Sweet taste receptor-activating molecules produced by sinus microbes suppress the local innate immune system in humans.

1 Comment

image: Bubbles for Broken Bones

Bubbles for Broken Bones

By | September 1, 2017

Ultrasound-stimulated microbubbles enable gene delivery to fix fractures.

0 Comments

image: Discovery of the Malaria Parasite, 1880

Discovery of the Malaria Parasite, 1880

By | September 1, 2017

Most didn’t believe French doctor Charles Louis Alphonse Laveran when he said he’d spotted the causative agent of the disease—and that it was an animal.

0 Comments

image: Far-Out Science

Far-Out Science

By | September 1, 2017

How psychedelic drugs and infectious microbes alter brain function

0 Comments

image: Decoding the Tripping Brain

Decoding the Tripping Brain

By | September 1, 2017

Scientists are beginning to unravel the mechanisms behind the therapeutic effects of psychedelic drugs.

2 Comments

image: Infographic: The Brain on Psychedelics

Infographic: The Brain on Psychedelics

By | September 1, 2017

Understanding how hallucinogenic drugs affect different neural networks could shed light on their therapeutic potential.

0 Comments

The new technique helped pig tibias heal in just eight weeks.

0 Comments

image: Smoking on a Chip

Smoking on a Chip

By | September 1, 2017

A new device from the Wyss Institute at Harvard University simulates the effects of cigarette smoke on human lungs.

0 Comments

image: Gilead to Pay Nearly $12B for CAR T-Cell Company

Gilead to Pay Nearly $12B for CAR T-Cell Company

By | August 28, 2017

The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.

0 Comments

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. Decoding the Tripping Brain
  3. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  4. Do Microbes Trigger Alzheimer’s Disease?
AAAS